Cargando…

Chronic Plaque Psoriasis in Poland: Disease Severity, Prevalence of Comorbidities, and Quality of Life

The epidemiology of psoriasis has not been widely assessed in Polish population so far. This study aimed to investigate psoriasis epidemiological situation by evaluating disease course and severity, management, comorbidities, environmental factors, and knowledge about this disorder among psoriatic p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Purzycka-Bohdan, Dorota, Kisielnicka, Anna, Zabłotna, Monika, Nedoszytko, Bogusław, Nowicki, Roman J., Reich, Adam, Samotij, Dominik, Szczęch, Justyna, Krasowska, Dorota, Bartosińska, Joanna, Narbutt, Joanna, Lesiak, Aleksandra, Barasińska, Paulina, Owczarczyk-Saczonek, Agnieszka, Czerwińska, Joanna, Szepietowski, Jacek C., Batycka-Baran, Aleksandra, Czajkowski, Rafał, Górecka-Sokołowska, Magdalena, Rudnicka, Lidia, Czuwara, Joanna, Sobalska-Kwapis, Marta, Strapagiel, Dominik, Szczerkowska-Dobosz, Aneta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911198/ https://www.ncbi.nlm.nih.gov/pubmed/35268344 http://dx.doi.org/10.3390/jcm11051254

Ejemplares similares

The Analysis of a Genome-Wide Association Study (GWAS) of Overweight and Obesity in Psoriasis
por: Kisielnicka, Anna, et al.
Publicado: (2022)

Pathogenesis of psoriasis in the “omic” era. Part II. Genetic, genomic and epigenetic changes in psoriasis
por: Nedoszytko, Bogusław, et al.
Publicado: (2020)

Pathogenesis of psoriasis in the “omic” era. Part III. Metabolic disorders, metabolomics, nutrigenomics in psoriasis
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2020)

Pathogenesis of psoriasis in the “omic” era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances
por: Samotij, Dominik, et al.
Publicado: (2020)

Pathogenesis of psoriasis in the “omic” era. Part IV. Epidemiology, genetics, immunopathogenesis, clinical manifestation and treatment of psoriatic arthritis
por: Szczerkowska-Dobosz, Aneta, et al.
Publicado: (2020)

Analysis of the Potential Genetic Links between Psoriasis and Cardiovascular Risk Factors
por: Purzycka-Bohdan, Dorota, et al.
Publicado: (2021)

Assessment of the Potential Role of Selected Single Nucleotide Polymorphisms (SNPs) of Genes Related to the Functioning of Regulatory T Cells in the Pathogenesis of Psoriasis
por: Purzycka-Bohdan, Dorota, et al.
Publicado: (2023)

New Insights into Psoriasis
por: Nedoszytko, Boguslaw, et al.
Publicado: (2022)

Risankizumab Therapy for Moderate-to-Severe Psoriasis—A Multi-Center, Long-Term, Real-Life Study from Poland
por: Adamczyk, Michał, et al.
Publicado: (2023)

The significance of Toll-like receptor (TLR) 2 and 9 gene polymorphisms in psoriasis
por: Zabłotna, Monika, et al.
Publicado: (2017)

Chemokine Profile in Psoriasis Patients in Correlation with Disease Severity and Pruritus
por: Purzycka-Bohdan, Dorota, et al.
Publicado: (2022)

Hyperhidrosis: disease aetiology, classification and management in the light of modern treatment modalities
por: Kisielnicka, Anna, et al.
Publicado: (2022)

Assessment of Interleukin 16 Serum Levels and Skin Expression in Psoriasis Patients in Correlation with Clinical Severity of the Disease
por: Purzycka-Bohdan, Dorota, et al.
Publicado: (2016)

Significance of interleukin-31 (IL-31) gene polymorphisms and IL-31 serum level in psoriasis in correlation with pruritus
por: Purzycka-Bohdan, Dorota, et al.
Publicado: (2021)

An Observational Study of 147 Psoriasis Patients: Overweightness and Obesity as a Significant Clinical Factors Correlated with Psoriasis
por: Czarnecka, Anna, et al.
Publicado: (2023)

Considerations of the Genetic Background of Obesity among Patients with Psoriasis
por: Czarnecka, Anna, et al.
Publicado: (2023)

The Effects of Vitamin D on the Expression of IL-33 and Its Receptor ST2 in Skin Cells; Potential Implication for Psoriasis
por: Wierzbicka, Justyna M., et al.
Publicado: (2021)

MicroRNA in localized scleroderma: a review of literature
por: Wolska-Gawron, Katarzyna, et al.
Publicado: (2019)

The effects of selected biologics and a small molecule on Health-Related Quality of Life in adult plaque psoriasis patients: A systematic review and meta-analysis
por: Karpińska-Mirecka, Anna, et al.
Publicado: (2020)

The Impact of Hypertension, Diabetes, Lipid Disorders, Overweight/Obesity and Nicotine Dependence on Health-Related Quality of Life and Psoriasis Severity in Psoriatic Patients Receiving Systemic Conventional and Biological Treatment
por: Karpińska-Mirecka, Anna, et al.
Publicado: (2021)

Genetic association of FTO/IRX region with obesity and overweight in the Polish population
por: Sobalska-Kwapis, Marta, et al.
Publicado: (2017)

Novel Application of Light-Emitting Diode Therapy in the Treatment of Eyebrow Loss in Frontal Fibrosing Alopecia
por: Gerkowicz, Agnieszka, et al.
Publicado: (2021)

Does molecular scarring in psoriasis exist? A review of the literature
por: Kasprowicz-Furmańczyk, Marta, et al.
Publicado: (2023)

Lysosome Alterations in the Human Epithelial Cell Line HaCaT and Skin Specimens: Relevance to Psoriasis
por: Bocheńska, Katarzyna, et al.
Publicado: (2019)

Correction: Bocheńska, K. et al. Lysosome Alterations in the Human Epithelial Cell Line HaCaT and Skin Specimens: Relevance to Psoriasis. Int. J. Mol. Sci. 2019, 20, 2255
por: Bocheńska, Katarzyna, et al.
Publicado: (2020)

The Impact of Biologic Treatment on PD-1/PD-L1 Pathway Disturbances in Psoriasis
por: Adamczyk, Michał, et al.
Publicado: (2023)

Characteristics of Pruritus in Various Clinical Variants of Psoriasis: Results of the Multinational, Multicenter, Cross-Sectional Study
por: Jaworecka, Kamila, et al.
Publicado: (2021)

The Impact of Pruritus on the Quality of Life and Sleep Disturbances in Patients Suffering from Different Clinical Variants of Psoriasis
por: Jaworecka, Kamila, et al.
Publicado: (2022)

UVB-induced bullous pemphigoid in a patient with psoriasis
por: Ceryn, Justyna, et al.
Publicado: (2020)

Carcinoma en cuirasse as an initial manifestation of inflammatory breast cancer
por: Reich, Adam, et al.
Publicado: (2016)

High Resolution Melting (HRM) for High-Throughput Genotyping—Limitations and Caveats in Practical Case Studies
por: Słomka, Marcin, et al.
Publicado: (2017)

Molecular action of isoflavone genistein in the human epithelial cell line HaCaT
por: Smolińska, Elwira, et al.
Publicado: (2018)

Multiple Cytokine Analysis of Th1/Th2/Th9/Th17/Th22/Treg Cytokine Pathway for Individual Immune Profile Assessment in Patients with Psoriasis
por: Michalak-Stoma, Anna, et al.
Publicado: (2022)

IL-17A in the Psoriatic Patients' Serum and Plaque Scales as Potential Marker of the Diseases Severity and Obesity
por: Michalak-Stoma, Anna, et al.
Publicado: (2020)

Circulating miRNA-181b-5p, miRNA-223-3p, miRNA-210-3p, let 7i-5p, miRNA-21-5p and miRNA-29a-3p in patients with localized scleroderma as potential biomarkers
por: Wolska-Gawron, Katarzyna, et al.
Publicado: (2020)

Assessment of Selected Matrix Metalloproteinases (MMPs) and Correlation with Cytokines in Psoriatic Patients
por: Michalak-Stoma, Anna, et al.
Publicado: (2021)

Nailfold Videocapillaroscopy in Patients with Central Serous Chorioretinopathy and Its Relationship to Morphological and Functional Findings
por: Latalska, Małgorzata, et al.
Publicado: (2020)

The Expression of Activation Markers CD25 and CD69 Increases during Biologic Treatment of Psoriasis
por: Adamczyk, Michał, et al.
Publicado: (2023)

Genetic background of skin barrier dysfunction in the pathogenesis of psoriasis vulgaris
por: Stawczyk-Macieja, Marta, et al.
Publicado: (2015)

Comment on the article “Buschke-Löwenstein tumour associated with low-risk human papillomavirus genotypes successfully treated surgically”
por: Purzycka-Bohdan, Dorota, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tod6qu2t1fgqa1247rsrtruhsh